Zenith Capital Corp.

OTC: ZHCLF · Healthcare · Biotechnology

Canadian filerHQ Calgary, ABReports USD

#925 of 1,394 Healthcare companies by revenue

EA Score

——

FH 15DQ —GM —SS 56

v0.1 · 35/100 weight · pillars only

↑ workforce scale, disclosure history · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

$500.0k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$7.3M

Employees

50,477

Market cap

$16.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$500.0k$500.0k2024

Net income-$7.3M-$7.3M2024

Operating income-$4.8M-$4.8M2024

Total assets$0$02024

Liabilities$0$02024

Equity$0$02024

Revenue trend

FY2017 – FY2024 · USD

FY17

FY18

FY19

FY20

FY21

FY22

FY23

$500.0k

FY24

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Zenith Capital Corp. booked $500.0k in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -1469.8% net margin.

Peers · Healthcare

Selectis Health, Inc.61C Brainstorm Cell Therapeutics Inc.——Marker Therapeutics, Inc.36D Exlites Holdings International, Inc.54D

Key facts

CEODonald J. McCaffrey

SectorHealthcare

IndustryBiotechnology

HeadquartersCalgary, AB

ExchangeOTC: ZHCLF

Employees50,477

IPO date2021-05-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.